Your browser doesn't support javascript.
loading
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients.
Monti, Paola; Lionetti, Marta; De Luca, Giuseppa; Menichini, Paola; Recchia, Anna Grazia; Matis, Serena; Colombo, Monica; Fabris, Sonia; Speciale, Andrea; Barbieri, Marzia; Gentile, Massimo; Zupo, Simonetta; Dono, Mariella; Ibatici, Adalberto; Neri, Antonino; Ferrarini, Manlio; Fais, Franco; Fronza, Gilberto; Cutrona, Giovanna; Morabito, Fortunato.
Afiliación
  • Monti P; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
  • Lionetti M; Department of Oncology and Hemato-Oncology, University of Milan, 20122, Milan, Italy.
  • De Luca G; Molecular Diagnostic Unit, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
  • Menichini P; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
  • Recchia AG; Biotechnology Research Unit, Aprigliano, A.O./ASP of Cosenza, 87100, Cosenza, Italy.
  • Matis S; Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Colombo M; Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Fabris S; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122, Milan, Italy.
  • Speciale A; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
  • Barbieri M; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122, Milan, Italy.
  • Gentile M; Hematology Unit, Department of Onco-Hematology, A.O. of Cosenza, 87100, Cosenza, Italy.
  • Zupo S; Molecular Diagnostic Unit, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
  • Dono M; Molecular Diagnostic Unit, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
  • Ibatici A; Hematology Unit and Bone Marrow Transplantation, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Neri A; Department of Oncology and Hemato-Oncology, University of Milan, 20122, Milan, Italy.
  • Ferrarini M; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122, Milan, Italy.
  • Fais F; Department of Experimental Medicine, University of Genoa, 16132, Genoa, Italy.
  • Fronza G; Molecular Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Cutrona G; Department of Experimental Medicine, University of Genoa, 16132, Genoa, Italy.
  • Morabito F; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
Sci Rep ; 10(1): 18427, 2020 10 28.
Article en En | MEDLINE | ID: mdl-33116240
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Genes p53 / Tiempo de Tratamiento Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Genes p53 / Tiempo de Tratamiento Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Italia